A risk-matrix guide for biomedical managers and procurement teams choosing between original and third-party parts for used equipment, current as of September 2026. It is not legal advice and it does not conclude that either category is always right.
The parts decision looks like a price comparison and behaves like a risk comparison. Two parts may be functionally similar and differ completely in who stands behind them, what they do to the device’s regulatory position, and what happens when the device fails after the part is fitted. The useful question is not “which is cheaper” but “what does fitting this part change”.
Parts choices change device risk
A part is not an isolated component; it sits inside a device that was validated as a whole. Replacing it can affect three things beyond the immediate repair: whether the device still performs as the manufacturer specified, whether the manufacturer will continue to support it, and whether the work has changed the device’s regulatory status.
That third point is the one that surprises teams. Regulators have addressed the boundary between servicing a device and changing it enough that the entity performing the work takes on a different role. In the United States, FDA published a final guidance on remanufacturing of medical devices in May 2024 which clarifies whether activities performed on a device are likely to be remanufacturing and clarifies existing requirements for entities that remanufacture. Where a parts decision crosses that boundary, it stops being a maintenance choice and becomes a question about your organization’s position.
OEM parts
Original parts carry three advantages that are easy to undervalue. They are the parts the device was validated with, so fitting them does not create a performance question. They keep the manufacturer’s support pathway open, which matters if the device later needs a repair the in-house team cannot perform. And their provenance is documented, which matters at acceptance and at audit.
The trade-offs are availability and cost. Lead times can be long for older platforms, and a part that is no longer supplied forces the decision back to you anyway.
Third-party and refurbished parts
Third-party parts occupy a wide range. At one end are components made to a published specification and supplied with traceability; at the other are parts whose origin cannot be established. Refurbished original parts sit in between: they began as the manufacturer’s component and have been reworked.
Two questions separate the ends of that range. Can the supplier document what the part is and where it came from? And will the organization fitting it be able to demonstrate, if asked, that the device still performs to specification? Where both answers are yes, the decision becomes commercial. Where either is no, it becomes a risk the buyer is taking on knowingly ¡ª which is a legitimate choice only when it is made explicitly.
| Consideration | OEM part | Third-party or refurbished part |
|---|---|---|
| Performance basis | The part the device was validated with | Depends on specification and documentation |
| Manufacturer support | Support pathway unaffected | May affect warranty or service terms; check the device terms |
| Traceability | Documented provenance | Varies; request documentation and treat its absence as a finding |
| Availability | Can be long lead time on older platforms | Often faster, which matters for downtime |
| Regulatory position | No change to the device’s status when the part is fitted through the manufacturer’s own service path | Work that changes performance may change the entity’s role ¡ª see FDA’s May 2024 remanufacturing guidance |
Safety, warranty and regulatory impact
Three consequences follow a parts decision, and they should be considered before the part is ordered rather than after it is fitted. Safety: does the device still meet the performance the manufacturer specified, and how will you demonstrate that? Warranty: what do the device’s service terms say about parts fitted by parties other than the manufacturer? Regulatory: has the work changed what the device is or does, and if so, what does that mean for your organization?
Write the answers into the maintenance record when the part is fitted. That record is what turns an undocumented substitution into a documented decision ¡ª and it is the difference between a defensible choice and an unexplained one.
Decision matrix by failure impact
| If the part fails, what happens? | Suggested approach |
|---|---|
| Cosmetic or convenience function only | Third-party parts are usually a reasonable commercial choice, with documentation |
| Deferred procedure, equipment taken out of service | Weigh availability against support implications; document the decision |
| Immediate patient-safety consequence | OEM parts and an authorised service pathway, with verification after the work |
| Device’s measured performance depends on the part | OEM or specification-documented parts, plus verification against the specification |
One further input belongs in the decision but rarely gets recorded: the availability of the part when you need it again. A third-party part that is easy to obtain in normal times and unavailable during a supply disruption is a different proposition from one with a predictable supply route, and the difference shows up exactly when downtime is most expensive. Where a part is on a critical device, ask the supplier what the lead time was over the last year rather than what it is today, and decide whether your organization can live with the worst of that range.
Documenting parts choices
- What was replaced, with the part number and the supplier.
- Whether the part was the manufacturer’s, refurbished, or third-party.
- Who performed the work and under what procedure.
- The verification performed after fitting, and its result.
- Any change to warranty or service terms that followed.
Questions buyers ask
Are third-party parts unsafe?
Not categorically. The variable is documentation and verification, not the category. A specification-compliant part with traceability and post-fitting verification is a different proposition from an unidentified component fitted without records.
Does fitting a third-party part void the warranty?
It depends on the device’s terms, and it is worth reading them before the part is ordered rather than after. Some terms address parts specifically; others address who performed the work.
Where does the regulatory line sit?
Between servicing and remanufacturing ¡ª that is the question FDA’s May 2024 guidance addresses. If the work changes device performance rather than restoring it, treat the regulatory question as part of the decision.
Decide by consequence, document the choice, and verify the result. If you are sourcing parts or equipment and want the records that should travel with them, ask HHG for the documentation on a specific item. Related reading: service manual use under compliance pressure and the growth of independent repair.